Auflistung nach Autor "Gallwitz, Baptist"

Anzeige der Dokumente 21-40 von 72

Gastrointestinale Hormone – zunehmende arzneitherapeutische Bedeutung bei Stoffwechselerkrankungen

Gallwitz, Baptist (2023)
Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advances

Gallwitz, Baptist (2016)
How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment

Gallwitz, Baptist (2013)
Hypothyroidism during second-line treatment of multidrug-resistant tuberculosis: a prospective study

Bares, Roland; Dittmann, Helmut; Reimold, Matthias; Gallwitz, Baptist (2016)
Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus

Gallwitz, Baptist (2013)
Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial

Gallwitz, Baptist (2015)
Inkretin-basierte Therapie: ein ergänzender Therapieansatz bei Patienten mit Typ-1-Diabetes?

Gallwitz, Baptist (2015)
Inkretinbasierte Therapien

Gallwitz, Baptist (2013)
Kardiovaskuläre Studien-Endpunkte bei Typ-2-Diabetes und die Sulfonylharnstoff-Kontroverse : Rationale für die aktiv kontrollierte CAROLINA®-Studie

Gallwitz, Baptist (2015)
Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials

Gallwitz, Baptist (2017)
Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA1c < 7% with no hypoglycaemia and no weight gain over 2years

Gallwitz, Baptist (2013)
Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia

Gallwitz, Baptist (2016)
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study

Gallwitz, Baptist (2015)
Low performance in attention testing is associated with reduced grey matter density of the left inferior frontal gyrus in euthyroid patients with Hashimoto's thyroiditis

Leyhe, Thomas; Ethofer, Thomas; Bretscher, Johannes; Künle, Andreas Markus; Säuberlich, Anna-Laura; Klein, Reinhild; Gallwitz, Baptist; Häring, Hans-Ulrich; Fallgatter, Andreas J.; Klingberg, Stefan; Saur, Ralf; Müssig, Karsten Thomas (2013)
Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin

Gallwitz, Baptist (2015)
Metabolische Wirkungen und kardiovaskuläre Sicherheit einer oralen Dreifachtherapie des Typ-2-Diabetes: das Beispiel Metformin, Empagliflozin und Linagliptin

Gallwitz, Baptist (2020)
New antihyperglycemic drugs

Gallwitz, Baptist (2014)
Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance

Heni, Martin; Schick, Fritz; Stefan, Norbert; Gallwitz, Baptist; Wagner, Róbert; Machann, Jürgen; Häring, Hans-Ulrich; Fritsche, Andreas Erwin (2017)
Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry

Stefan, Norbert; Sippel, Katrin; Heni, Martin; Fritsche, Andreas Erwin; Wagner, Róbert; Preißl, Hubert; Gallwitz, Baptist; Birkenfeld, Andreas L. (2022)
Optionen zur Intensivierung einer Basalinsulintherapie bei Menschen mit Typ-2-Diabetes

Gallwitz, Baptist (2015)

Anzeige der Dokumente 21-40 von 72

Veröffentlichen

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Einloggen

Auflistung nach Autor "Gallwitz, Baptist"

Auflistung nach Autor "Gallwitz, Baptist"

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Hilfe & Infos